These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 8320928

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients.
    Ricci Z, Garisto C, Morelli S, Di Chiara L, Ronco C, Picardo S.
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):33-6. PubMed ID: 19339274
    [Abstract] [Full Text] [Related]

  • 24. Good biocompatibility of the polyamide hemofilter.
    von Herrath D, Hüfler M, Hartenstein-Koch K, Kutschera D, Schaefer K, Dati F.
    Blood Purif; 1988 Jul; 6(2):106-10. PubMed ID: 3395472
    [Abstract] [Full Text] [Related]

  • 25. The place of intermittent hemodialysis in the treatment of acute renal failure in the ICU patient.
    Lameire N, Van Biesen W, Vanholder R, Colardijn F.
    Kidney Int Suppl; 1998 May; 66():S110-9. PubMed ID: 9573586
    [No Abstract] [Full Text] [Related]

  • 26. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital.
    Chuasuwan A, Gojaseni P, Chittinandana A.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459
    [Abstract] [Full Text] [Related]

  • 27. Are changes in intracranial pressure during intermittent machine haemofiltration dependent upon membrane biocompatibility?
    Davenport A, Davison AM, Will EJ.
    Int J Artif Organs; 1989 Nov; 12(11):703-7. PubMed ID: 2599669
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure.
    Davenport A, Will EJ, Davison AM.
    Nephrol Dial Transplant; 1990 Nov; 5(3):192-8. PubMed ID: 2113646
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Biocompatibility of the polyamide membranes.
    Deppisch R, Betz M, Hänsch GM, Rauterberg EW, Ritz E.
    Contrib Nephrol; 1992 Nov; 96():26-46. PubMed ID: 1740049
    [No Abstract] [Full Text] [Related]

  • 35. Antithrombogenicity of polyacrylonitrile-polyethyleneoxide hollow fiber membrane developed for designing an antithrombogenic continuous ultrafiltration system.
    Arakawa M, Aoike I, Sizuki Y, Gejyo F, Terada R, Sugaya H, Takeyama T, Kunitomo T.
    Artif Organs; 1992 Apr; 16(2):146-50. PubMed ID: 10078236
    [Abstract] [Full Text] [Related]

  • 36. High-permeability membrane hemodialysis and hemofiltration in acute hepatic coma: experimental and clinical results.
    Opolon P.
    Artif Organs; 1979 Nov; 3(4):354-60. PubMed ID: 533427
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Determinants of drug removal by continuous hemofiltration.
    Lau AH, Kronfol NO.
    Int J Artif Organs; 1994 Jul; 17(7):373-8. PubMed ID: 7806423
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.